BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2940560)

  • 21. [Pemphigus folliaceous following D-penicillamine in rheumatoid arthritis].
    Brenner S; Caspi D; Tchetchik R; Krakowski A; Yaron M
    Harefuah; 1983 Feb; 104(3):94-6. PubMed ID: 6618302
    [No Abstract]   [Full Text] [Related]  

  • 22. [A chemically induced polyneuropathy in chronic polyarthritis treated with D-penicillamine?].
    Mayr N; Graninger W; Wessely P
    Wien Klin Wochenschr; 1983 Feb; 95(3):86-8. PubMed ID: 6305039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophilia in rheumatoid patients treated with D-penicillamine.
    Edelman J; Maguire KF; Owen ET
    J Rheumatol; 1984 Oct; 11(5):624-5. PubMed ID: 6512792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-penicillamine toxicity in Greek patients with rheumatoid arthritis: anti-Ro(SSA) antibodies and cryoglobulinemia are predictive factors.
    Vlachoyiannopoulos PG; Zerva LV; Skopouli FN; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1991 Jan; 18(1):44-9. PubMed ID: 1827158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myasthenia as a complication of D-penicillamine therapy of rheumatoid arthritis].
    Krikunov VP; Gubar' EE; Mogucheva IV; Shagal DI
    Ter Arkh; 1987; 59(4):139-41. PubMed ID: 3589994
    [No Abstract]   [Full Text] [Related]  

  • 26. [Polymyositis induced by D-penicillamine treatment of rheumatoid arthritis: apropos of 2 cases with antinuclear antibodies].
    Masson CJ; Ménard HA; Audran M; Renier JC; Lussier A; Myhal DM
    Union Med Can; 1986 Dec; 115(12):855-9. PubMed ID: 3492802
    [No Abstract]   [Full Text] [Related]  

  • 27. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.
    Bucknall RC
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):114-7. PubMed ID: 122656
    [No Abstract]   [Full Text] [Related]  

  • 28. Dermatomyositis during adalimumab therapy for rheumatoid arthritis.
    Brunasso AM; Scocco GL; Massone C
    J Rheumatol; 2010 Jul; 37(7):1549-50. PubMed ID: 20595297
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myasthenia induced by D-penicillamine during the treatment of rheumatoid polyarthritis].
    Carter H; Job-Deslandre C; Delrieu F; Kahan A; Menkès CJ
    Rev Rhum Mal Osteoartic; 1986 May; 53(5):341-4. PubMed ID: 3738397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-penicillamine-induced polymyositis occurring in patients with rheumatoid arthritis: a report of two cases and demonstration of a positive lymphocyte stimulation test to D-penicillamine.
    Matsumura T; Yuhara T; Yamane K; Kono I; Kabashima T; Kashiwagi H
    Henry Ford Hosp Med J; 1986; 34(2):123-6. PubMed ID: 3489699
    [No Abstract]   [Full Text] [Related]  

  • 31. [Penicillamine-induced polymyositis (author's transl)].
    Bettendorf U; Neuhaus R
    Dtsch Med Wochenschr; 1974 Dec; 99(49):2513, 2522-5. PubMed ID: 4548017
    [No Abstract]   [Full Text] [Related]  

  • 32. [D-penicillamine induced lupus during the treatment of rheumatoid arthritis. Report of 2 cases and systematic immunologic study during the treatment].
    Crouzet J; Camus JP; Leca AP; Guillien P; Lièvre JA
    Ann Med Interne (Paris); 1974 Jan; 125(1):71-9. PubMed ID: 4136184
    [No Abstract]   [Full Text] [Related]  

  • 33. D-penicillamine-induced myasthenia gravis in rheumatoid arthritis.
    Froelich CJ; Hashimoto F; Searles RP; Bankhurst AD
    J Rheumatol; 1979; 6(2):237-9. PubMed ID: 458795
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of rheumatoid arthritis associated with leukocytopenia during D-penicillamine treatment].
    Negishi M; Sato H; Sekine F; Mita S; Ono I; Kobayashi K; Oseto Y; Hamai T; Takahashi T
    Arerugi; 1982 Jun; 31(6):350-4. PubMed ID: 7181659
    [No Abstract]   [Full Text] [Related]  

  • 35. [Myasthenia gravis as a complication of D-penicillamine treatment in rheumatoid arthritis].
    Ongerboer de Visser BW; van Soesbergen RM
    Ned Tijdschr Geneeskd; 1978 Dec; 122(52):2055-8. PubMed ID: 732905
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood cytopenias induced by D-penicillamine in rheumatoid arthritis - a report of 51 patients (author's transl)].
    Aymard JP; Netter P; Witz F; Colomb JN; Lederlin P; Pourel J; Gaucher A; Herbeuval R
    Therapie; 1981; 36(3):337-41. PubMed ID: 7292413
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adverse effects of D-penicillamine in rheumatoid arthritis with reference to prior gold therapy].
    Ishihara Y; Fujita A; Ohdoi S; Saitoh K; Katsube S; Azuma T
    Ryumachi; 1985 Feb; 25(1):15-9. PubMed ID: 4002060
    [No Abstract]   [Full Text] [Related]  

  • 38. Diffuse fasciculations induced by D-penicillamine.
    Pinals RS
    J Rheumatol; 1983 Oct; 10(5):809-10. PubMed ID: 6644706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acetylcholine receptor antibody in D-penicillamine therapy].
    Kolarz G; Maida EM
    Z Rheumatol; 1986; 45(3):118-21. PubMed ID: 3751350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.